Alopecia News

ORLANDO — Outgoing American Academy of Dermatology President Seemal R. Desai, MD, FAAD, passed the torch to Susan C. Taylor, MD, FAAD, who said she will continue pushing efforts to unify the organization during “a time of great disruption.”

ORLANDO — Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in adults with severe alopecia areata, according to phase 3 data presented here.

ORLANDO — Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and eyelashes compared with placebo in adolescents with severe alopecia areata, data show.

MIAMI BEACH, Fla. — Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to a presentation at South Beach Symposium.

MIAMI BEACH, Fla. — As interest in alternative treatment options grow, a speaker at South Beach Symposium shared her go-to nutrition guidelines for patients suffering from hair loss.

Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter published in Allergy.

Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, Eirion Therapeutics announced in a press release.

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.

SARS-CoV-2 infection, especially a severe case or without vaccination, significantly increases the long-term risk for developing autoimmune and autoinflammatory connective tissue diseases, according to data published in JAMA Dermatology.